OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
Elena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 666-666
Open Access | Times Cited: 21

Showing 21 citing articles:

The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia
Mohamed El‐Tanani, Hamdi Nsairat, Ismail Matalka, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155161-155161
Open Access | Times Cited: 12

Role of c-Src in Carcinogenesis and Drug Resistance
Lukmon Raji, Angelina Tetteh, A.R.M. Ruhul Amin
Cancers (2023) Vol. 16, Iss. 1, pp. 32-32
Open Access | Times Cited: 19

Advances in Melanoma: From Genetic Insights to Therapeutic Innovations
Fernando Valdez-Salazar, Luis Alberto Jiménez-Del Río, Jorge Ramón Padilla‐Gutiérrez, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1851-1851
Open Access | Times Cited: 6

KDM6A Regulates Immune Response Genes in Multiple Myeloma
Daphne Dupéré-Richer, Alberto Riva, Benjamin G. Barwick, et al.
Blood (2024) Vol. 144, Iss. 14, pp. 1508-1520
Open Access | Times Cited: 5

Comprehensive characterization of respiratory genes based on a computational framework in pan-cancer to develop stratified treatment strategies
Caiyu Zhang, Chenyu Liu, Zhuoru Wang, et al.
PLoS Computational Biology (2025) Vol. 21, Iss. 4, pp. e1012963-e1012963
Open Access

Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies
Ioanna Ε. Stergiou, C. Tsironis, Stavros P. Papadakos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2369-2369
Open Access | Times Cited: 4

Leveraging altered lipid metabolism in treating B cell malignancies
Jae Woong Lee, Arya Mani, Min‐Jeong Shin, et al.
Progress in Lipid Research (2024) Vol. 95, pp. 101288-101288
Open Access | Times Cited: 3

Innate immune response in COVID-19: single-cell multi-omics profile of NK lymphocytes in a clinical case series
Silvia Barbon, Fabrizio Armellin, Verena Passerini, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Association of Neurokinin-1 Receptor Signaling Pathways with Cancer
Francisco D. Rodríguez, Rafael Coveñas
Current Medicinal Chemistry (2023) Vol. 31, Iss. 39, pp. 6460-6486
Closed Access | Times Cited: 3

Potential network markers and signaling pathways for B cells of COVID-19 based on single-cell condition-specific networks
Ying Li, Liqin Han, Peiluan Li, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma
Yuying Chen, Jialin Tang, Lin Chen, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 11, pp. 3074-3087
Open Access | Times Cited: 2

Case report: The cardio-facio-cutaneous syndrome due to a novel germline mutation in MAP2K1: A multifaceted disease with immunodeficiency and short stature
Aleksandra Szczawińska-Popłonyk, Natalia Popłonyk, Marek Niedziela, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 4

Identification of Immune-Related Gene Pair Signature to Predict Prognosis of Diffuse Large B-Cell Lymphoma Based on Bioinformatics Analyses
Zeinab Davoodi‐Moghaddam, Farideh Jafari‐Raddani, Davood Bashash
Cancer Investigation (2024), pp. 1-18
Closed Access

The role of the JunD-RhoH axis in the pathogenesis of hairy cell leukemia and its ability to identify existing therapeutics that could be repurposed to treat relapsed or refractory disease
Carl Simon Shelley, Sylvie Galiègue‐Zouitina, Leslie A. Andritsos, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-19
Closed Access

KDM6A Regulates Immune Response Genes in Multiple Myeloma
Daphne Dupéré-Richer, Alberto Riva, Sayantan Maji, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Up-regulated transcriptional regulators in mutant RAS gene signatures: a time-resolved multi-omics study in generic epithelial cell models
Katharina Kasack, Patrick Metzger, Heiner Koch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Coexistence of three hematological malignancies in association with a first time documented mutation: “One train can hide another”°, and even more!
Tamim Alsuliman, Souhila Ikhlef, Nicolas Stocker, et al.
Current Research in Translational Medicine (2023) Vol. 71, Iss. 3, pp. 103403-103403
Closed Access

Network and Computational Drug Repurposing Analysis for c-Myc Inhibition in Burkitt Lymphoma
Y. Lee, Seungyoon Nam
Cancer Genomics & Proteomics (2023) Vol. 20, Iss. 6suppl, pp. 712-722
Open Access

Page 1

Scroll to top